Breakthrough drug nearly doubles survival rate for advanced pancreatic cancer

AI justification

Life-saving medical breakthrough with high societal impact. | The development and potential deployment of a breakthrough drug that nearly doubles survival rates for advanced pancreatic cancer is a major positive ethical outcome. It directly advances SDG 3 (Good Health and Well-being) and upholds the right to health under the UDHR. The magnitude is high due to the life-saving potential and broad societal impact.